subhrajit biswas
Amity Institute of Molecular Medicine & Stem Cell Research, Amity University
Noida, India
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Editors
Review Editors
hella anna bolck
University Hospital Zürich
Zurich, Switzerland
Review Editor
Cancer Molecular Targets and Therapeutics
mathilde bonnet
Université Clermont Auvergne
Clermont-Ferrand, France
Review Editor
Cancer Molecular Targets and Therapeutics
francois bordeleau
Laval University
Quebec, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
maria grazia borrello
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
sergio bracarda
Azienda Ospedaliera Santa Maria Terni
Terni, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
christine fillmore brainson
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
matthew f. buas
Roswell Park Comprehensive Cancer Center, University at Buffalo
Buffalo, United States
Review Editor
Cancer Molecular Targets and Therapeutics
bojan bujisic
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
elena butturini
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona
Verona, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
siao muk cheng
National Institute of Cancer Research, National Health Research Institutes (Taiwan)
Miaoli, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics
yukti choudhury
Consultant
Singapore, Singapore
Review Editor
Cancer Molecular Targets and Therapeutics
pradeep reddy cingaram
University of Miami
Coral Gables, United States
Review Editor
Cancer Molecular Targets and Therapeutics
maria munoz caffarel
Biodonostia Health Research Institute (IIS Biodonostia)
San Sebastian, Spain
Review Editor
Cancer Molecular Targets and Therapeutics
long cai
Department of the Clinical Medical Examination and Experiment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Zhejiang, China
Hangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
fabio calabro'
IRCCS Istituto Nazionale Tumori Regina Elena
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics